BofA: The 3 Market Risks You Haven’t Thought About

One relates to the pandemic, one to politics, and one to federal stimulus.


They say the stock market climbs a wall of worry. A lot of sophisticated investors are modeling for risks up ahead, ranging from a long coronavirus siege to even worse economic news.

But Bank of America Securities has three more risks that aren’t getting much, if any attention—and are entirely plausible. To the unit’s research chief, Jared Woodard, and his team, these “are surprises that could have big impacts on the markets.”

And why not? This century has already hit us with two massive surprises: a housing boom that poisoned the entire world financial system and almost destroyed it, and a pandemic that has disrupted how people live, killed hundreds of thousands, and upended the system yet again.

Here’s what, according to their research note, may knock us off our feet next:

Want the latest institutional investment industry
news and insights? Sign up for CIO newsletters.

A vaccine conquers the virus, and soon. That would bring back a form of the world we used to know. “Financial assets are not priced for a return to normal,” BofA said. OK, this is a problem we’d all love to have.

Right now, pharma firms from Moderna to Regeneron are feverishly working on vaccines and treatments for COVID-19. Of course, there are the Russians, who are rushing their vaccine into use, to the dismay of many medical experts who fear it hasn’t been adequately tested for safety and effectiveness.

What would this all mean for investors? Surely, it would boost the market even higher. Asset allocation would shift, too. To the BofA research folks, “the risk worth considering is that an early vaccine could spark a significant tactical rotation out of deflationary defensives and into cyclical sectors.”

Election stalemate leads to House-selected president. Today, talk abounds about how the election might end up contested in the courts amid recounts, a true nightmare. How might it end up if no candidate got the needed 270 electoral votes?

According to the Constitution, the House would select the winner, with the stipulation that each state’s delegation gets one vote. So California, with 53 House members would count as much as Montana, with one. Result: Donald Trump would likely get re-elected. You think partisanship in Washington is bad now? The market will not like that kind of environment.

No new stimulus gets passed.  A lot of federal rescue programs, enacted in the spring, are expiring. The extra $600 in unemployment benefits is now history. And the two sides of the debate—the GOP-run Senate and the Democrat-controlled House—are in a stalemate. As we pass Labor Day and the election season heats up, getting anything done on Capitol Hill will be unlikely. This will bring a lot of financial pain to many American households, and will no doubt be a bad influence on the economy. Not to mention stocks.

As BofA put the matter, “Only a market correction would wake policymakers from their dogmatic slumber. While others are hedging the election, consider preparing for a Q3 buying opportunity.”

Related Stories:

Tail Risk Hedges Are Vital for Investors Now, Argues Black Swan Theory Guy

Chinese Virus Could Be a ‘Black Swan Like No Other’: Moody’s

Look Out, Here Come the Grey Swans

Tags: , , , , , , ,

NZ Super Fund, Ontario Teachers’ Buy Australian Pathology Firm 

The pension funds are each taking a 50% stake in Asia Pacific Healthcare Group in a $362 million sale. 


The New Zealand Superannuation Fund and the Ontario Teachers’ Pension Plan (OTPP) Board bought a pathology business this month in a $362 million sale. This marks a major pension push into the health industry, with a company that is at the center of the fight against the coronavirus.

The pension funds will each take a 50% stake in Asia Pacific Healthcare Group (APHG), the largest New Zealand pathology business under Healthscope, Australia’s largest private health care operator, according to a release

APHG, which provides services to three-quarters of New Zealand’s population, has been “heavily involved” in the country’s coronavirus response, according to the release. New Zealand has been praised for its handling of the pandemic, though it reported four new COVID-19 cases this week after more than three months without one. 

“Never has the value of excellent health care and pathology services been more apparent than in the ongoing COVID-19 crisis,” NZ Super Fund Chief Investment Officer Stephen Gilmore said in a statement. 

Never miss a story — sign up for CIO newsletters to stay up-to-date on the latest institutional investment industry news.

“We’re pleased to return this asset to part local ownership and continue our strong investment into New Zealand,” Gilmore continued. About NZ$6 billion of the NZ$46 billion fund, or US$4 billion of the US$30.3 billion, is invested locally. 

Healthscope, which started searching for prospective buyers at the start of the year, said the sale is consistent with its “long-term strategic refocus” on its hospital divisions in Australia. 

For Ontario Teachers, the acquisition is in line with other recent health care investments the C$207.4 billion fund has made. About 11% of its C$39.3 billion, or US$29.7 billion, private equity portfolio is invested in health care. In 2019, the OTPP led a C$140 million, or US$106 million, fundraising round into Swedish digital health care provider KRY International that allows consumers to see doctors through their smartphones.

The transaction is expected to close by February 2021, pending approval from New Zealand’s Overseas Investment Office.

Related Stories: 

New Zealand Super to Divest from Seven Gun Companies

New Zealand Super’s Proxy Drive Against Big Tech Grows to 23 Institutions

Ontario Teachers’ Strikes Gold in Flexible Natural Resources Deal

Tags: , , , , ,

«